Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2024-02-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities, specifically focusing on authorized and issued share capital, share options, convertibles, and confirmations related to securities issued by Reliance Global Holdings Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The document does not contain financial performance data, earnings, or management discussion but is a regulatory submission about share capital and securities movements. This type of document fits the category of Regulatory Filings (RNS) as it is a compliance report submitted to the exchange and does not constitute a financial report, earnings release, or capital/financing update per se. The document length is over 10,000 characters and contains detailed tables and confirmations, consistent with a regulatory filing rather than a brief announcement or report publication notice.
2024-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 January 2024. It details movements in authorized/registered share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movements for a specific month. It is not a financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital and share movements as required by exchange rules. The document length is 4442 characters, which is relatively short and focused on regulatory compliance information rather than a full report. Therefore, the best classification is Regulatory Filings (RNS), as it is a general regulatory announcement about share capital and share movements that does not fit other specific categories.
2024-02-01 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sisram Medical Ltd about entering into a strategic partnership with Prollenium to expand its product portfolio. It does not contain financial statements, regulatory certifications, voting results, or detailed financial data. The document is relatively short (2439 characters) and serves as a business update rather than a formal financial report or regulatory filing. It is not an announcement of a report publication, nor does it fit into categories like earnings release, capital update, or management changes. The content is best classified as a general regulatory announcement or miscellaneous filing that does not fit other specific categories.
2024-01-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities for Reliance Global Holdings Limited, submitted to the Hong Kong Exchanges and Clearing Limited. It includes information on authorized and issued share capital, movements in issued shares, convertibles, and confirmations related to securities issuance. The document is regulatory in nature, reporting share capital and share issuance movements for a specific month (December 2023). It does not contain financial statements, earnings data, management discussion, or audit information. It is not an announcement of a report but a regulatory filing required by the exchange rules. Therefore, it fits best under Regulatory Filings (RNS) as a general compliance and disclosure document related to share capital movements under exchange listing rules.
2024-01-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on changes in authorised and issued share capital for Sisram Medical Ltd. It includes data on share increases, confirmations by the board, and compliance with listing rules on the Hong Kong Stock Exchange. The document is structured as a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital changes and confirmations rather than financial performance or management commentary. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report but a regulatory filing reporting share capital movements and confirmations. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-01-03 English
Interim Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2023' for Reliance Global Holdings Limited and contains detailed financial statements and management discussion and analysis for the six months ended 30 September 2023. It includes condensed consolidated interim financial statements, profit and loss statements, financial position, cash flows, notes, and other information typical of an interim or quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a full interim report rather than a brief announcement or certification. Therefore, the appropriate classification is 'Interim / Quarterly Report' (IR). H1 2023
2023-12-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.